Healthy Skepticism Library item: 6685

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

MaLAM letter follow up—IFPMA rulings: “Unsurpassed” dishonesty
MaLAM International News 1996 Jul-Aug; 14:(7-8):1-2

Abstract:

The IFPMA has judged that Parke-Davis’ promotion of Ponstan does not breech the IFPMA code despite clear evidence that it does. This ruling discredits the whole code with health professionals.

Keywords:
*analysis/Pakistan/developing countries/Parke-Davis/Ponstan/children/antipyretics/ regulation of promotion/ Code of Pharmaceutical Marketing Practices (IFPMA)/ IFPMA/ International Federation of Pharmaceutical Manufacturers Associations/MaLAM/Medical Lobby for Appropriate Marketing/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES/REGULATION, CODES, GUIDELINES: INDUSTRY SELF-REGULATION